John Brooks

Sharp Edge Labs, Inc. develops biosensors to the cellular biology research community. It operates as a assay development company that offers products and services for drug discovery. The firm offers fluorogenic activating protein, which provides accurate and detailed detection method for cellular changes that is amendable to high-throughput screening and detailed follow-up. The company was founded by Alan S. Waggoner and Marcel P. Bruchez in 2010 and is headquartered in Pittsburgh, PA.

Noxilizer, Inc. engages in the provision of room temperature nitrogen dioxide sterilization technology. It sells sterilization equipment and biodecontamination equipment to pharmaceutical, biotech, and medical device manufacturers and also offers contract sterilization services. The company was founded in 2004 and is headquartered in Baltimore, MD.

Sharp Edge Labs, Inc. develops biosensors to the cellular biology research community. It operates as a assay development company that offers products and services for drug discovery. The firm offers fluorogenic activating protein, which provides accurate and detailed detection method for cellular changes that is amendable to high-throughput screening and detailed follow-up. The company was founded by Alan S. Waggoner and Marcel P. Bruchez in 2010 and is headquartered in Pittsburgh, PA.

Alertgy, Inc. engages in the development of a device for diabetes. Its product, Alerty GM, is a wristband that works with a mobile application to measure blood sugar. The company was founded by Marc E. Rippen and is headquartered in Melbourne, FL.

Hygieia, Inc. engages in the provision of healthcare services focusing on insulin management. It offers the d-Nav Insulin Management Program. The company was founded by Israel Hodish and Eran Bashan in 2008 and is headquartered in Livonia, MI.

Thermalin, Inc. engages in the development of insulin products for patients with diabetes. It offers stabilized, ultra-rapid, and highly concentrated; no refrigeration basal and mix; glucose-responsive smart basal; and StampPump insulins. The company was founded by Michael A. Weiss, Bruce H. Frank, and Richard Berenson in 2010 and is headquartered in Cleveland, OH.

Theromics, Inc. is a medical device technology company that is developing a next-generation thermal accelerant technology for soft tissue ablation procedures and combination therapy. The company is based in West Bridgewater, MA. The company's proprietary heatsync™ gel is based on a protein naturally found in the body and may increase cost-efficiencies and improve outcomes through more focused and patient-centric delivery. The company will first focus on tumor ablations and then expand into additional applications, including pain and abnormal uterine bleeding. Longer-term, Theromics plans to apply its thermal technology for use as an oncolytic intratumoral drug/immunotherapy delivery platform with the potential to enhance efficacy and improve safety profiles of currently approved medicines. The company was founded by Damian E. Dupuy, William Keun Chan Park. The CEO is Ron Murphy.

Thermalin, Inc. engages in the development of insulin products for patients with diabetes. It offers stabilized, ultra-rapid, and highly concentrated; no refrigeration basal and mix; glucose-responsive smart basal; and StampPump insulins. The company was founded by Michael A. Weiss, Bruce H. Frank, and Richard Berenson in 2010 and is headquartered in Cleveland, OH.

T1D Exchange is a nonprofit organization that was established in 2010 with initial and ongoing support from the Leona M. and Harry B. Helmsley Charitable Trust. T1D Exchange is based in Boston, MA. The non-profit company is dedicated to improving outcomes for the entire T1D population through real-world evidence and clinical data collection and analysis. T1D Exchange is a leading provider of real-world evidence, identifying gaps in data and redefining best practices to improve the lives of those living with T1D. The company actively supports quality improvement and innovation through its quality improvement collaborative, patient registry, and data-oriented research services. David Walton has been the CEO of the company since 2018.

HemoShear Therapeutics LLC engages in the development of human-relevant systems for applications in drug research and development. It creates human relevant systems that replicate the biology of organ systems and diseases throughout drug discovery and development. The firm's technology imposes human-derived hemodynamic forces on human primary cells to recreate human biology. The company was founded by Brian R. Wamhoff and Brett R. Blackman in 2008 and is headquartered in Charlottesville, VA.

Noxilizer, Inc. engages in the provision of room temperature nitrogen dioxide sterilization technology. It sells sterilization equipment and biodecontamination equipment to pharmaceutical, biotech, and medical device manufacturers and also offers contract sterilization services. The company was founded in 2004 and is headquartered in Baltimore, MD.

Massachusetts Medical Device Industry Council, also known as MassMEDIC, is the largest regional medtech association in Massachusetts. With over 300 members, the organization represents manufacturers, product developers, suppliers, research institutions, and academic health centers.

Population Health Alliance is a professional and trade association that has been advocating for population health management for over 20 years. The private company is based in Washington. The American company believes that applying the principles of population health improvement will lead to better health outcomes for all individuals and populations.

Altrixbio, Inc. develops novel drugs that target metabolic diseases. The company is based in Cambridge, MA. The company was founded in 2019 by Ali Tavakkoli, Jeffrey Karp, Nancy Briefs. Nancy Briefs has been the CEO since 2019.

Altrixbio, Inc. develops novel drugs that target metabolic diseases. The company is based in Cambridge, MA. The company was founded in 2019 by Ali Tavakkoli, Jeffrey Karp, Nancy Briefs. Nancy Briefs has been the CEO since 2019.

Theromics, Inc. is a medical device technology company that is developing a next-generation thermal accelerant technology for soft tissue ablation procedures and combination therapy. The company is based in West Bridgewater, MA. The company's proprietary heatsync™ gel is based on a protein naturally found in the body and may increase cost-efficiencies and improve outcomes through more focused and patient-centric delivery. The company will first focus on tumor ablations and then expand into additional applications, including pain and abnormal uterine bleeding. Longer-term, Theromics plans to apply its thermal technology for use as an oncolytic intratumoral drug/immunotherapy delivery platform with the potential to enhance efficacy and improve safety profiles of currently approved medicines. The company was founded by Damian E. Dupuy, William Keun Chan Park. The CEO is Ron Murphy.

Basys.Ai LLC is a healthcare platform that utilizes generative AI to simplify prior authorization and utilization management. The platform promotes transparency and collaboration among healthcare insurers, providers, and other stakeholders to reduce administrative and medical costs and improve healthcare outcomes. The American company was founded by Amber Nigam and Jie Sun, with Amber Nigam serving as CEO since incorporation.

Basys.Ai LLC is a healthcare platform that utilizes generative AI to simplify prior authorization and utilization management. The platform promotes transparency and collaboration among healthcare insurers, providers, and other stakeholders to reduce administrative and medical costs and improve healthcare outcomes. The American company was founded by Amber Nigam and Jie Sun, with Amber Nigam serving as CEO since incorporation.

Maroon Venture Partners LLC (Maroon Venture Partners) is a venture capital firm founded in 2016. The firm is headquartered in Amherst, Massachusetts.

HemoShear Therapeutics LLC engages in the development of human-relevant systems for applications in drug research and development. It creates human relevant systems that replicate the biology of organ systems and diseases throughout drug discovery and development. The firm's technology imposes human-derived hemodynamic forces on human primary cells to recreate human biology. The company was founded by Brian R. Wamhoff and Brett R. Blackman in 2008 and is headquartered in Charlottesville, VA.

HemoShear Therapeutics LLC engages in the development of human-relevant systems for applications in drug research and development. It creates human relevant systems that replicate the biology of organ systems and diseases throughout drug discovery and development. The firm's technology imposes human-derived hemodynamic forces on human primary cells to recreate human biology. The company was founded by Brian R. Wamhoff and Brett R. Blackman in 2008 and is headquartered in Charlottesville, VA.

Noxilizer, Inc. engages in the provision of room temperature nitrogen dioxide sterilization technology. It sells sterilization equipment and biodecontamination equipment to pharmaceutical, biotech, and medical device manufacturers and also offers contract sterilization services. The company was founded in 2004 and is headquartered in Baltimore, MD.

Massachusetts Medical Device Industry Council, also known as MassMEDIC, is the largest regional medtech association in Massachusetts. With over 300 members, the organization represents manufacturers, product developers, suppliers, research institutions, and academic health centers.

Hygieia, Inc. engages in the provision of healthcare services focusing on insulin management. It offers the d-Nav Insulin Management Program. The company was founded by Israel Hodish and Eran Bashan in 2008 and is headquartered in Livonia, MI.

Massachusetts Medical Device Industry Council, also known as MassMEDIC, is the largest regional medtech association in Massachusetts. With over 300 members, the organization represents manufacturers, product developers, suppliers, research institutions, and academic health centers.

Population Health Alliance is a professional and trade association that has been advocating for population health management for over 20 years. The private company is based in Washington. The American company believes that applying the principles of population health improvement will lead to better health outcomes for all individuals and populations.

Massachusetts Medical Device Industry Council, also known as MassMEDIC, is the largest regional medtech association in Massachusetts. With over 300 members, the organization represents manufacturers, product developers, suppliers, research institutions, and academic health centers.

Basys.Ai LLC is a healthcare platform that utilizes generative AI to simplify prior authorization and utilization management. The platform promotes transparency and collaboration among healthcare insurers, providers, and other stakeholders to reduce administrative and medical costs and improve healthcare outcomes. The American company was founded by Amber Nigam and Jie Sun, with Amber Nigam serving as CEO since incorporation.

Population Health Alliance is a professional and trade association that has been advocating for population health management for over 20 years. The private company is based in Washington. The American company believes that applying the principles of population health improvement will lead to better health outcomes for all individuals and populations.

Thermalin, Inc. engages in the development of insulin products for patients with diabetes. It offers stabilized, ultra-rapid, and highly concentrated; no refrigeration basal and mix; glucose-responsive smart basal; and StampPump insulins. The company was founded by Michael A. Weiss, Bruce H. Frank, and Richard Berenson in 2010 and is headquartered in Cleveland, OH.

Population Health Alliance is a professional and trade association that has been advocating for population health management for over 20 years. The private company is based in Washington. The American company believes that applying the principles of population health improvement will lead to better health outcomes for all individuals and populations.

Massachusetts Medical Device Industry Council, also known as MassMEDIC, is the largest regional medtech association in Massachusetts. With over 300 members, the organization represents manufacturers, product developers, suppliers, research institutions, and academic health centers.

Senscio Systems, Inc. develops digital health solutions that provide information and support for consumers and clinicians. It offers Ibis solution, which provides a clinical safety net that enables care in the least restrictive setting for people with complex clinical, social, and behavioral conditions. The firm’s Ibis recognizes emerging health issues and care gaps in real time, provides self-care protocols, and alerts the care team to early intervention opportunities, avoiding the need for hospitalization using patent-pending artificial intelligence. The company was founded by Pilai De, Hugh Franklin Stoddart and Hugh A. Stoddart in 2010 and is headquartered in Boxborough, MA.

Senscio Systems, Inc. develops digital health solutions that provide information and support for consumers and clinicians. It offers Ibis solution, which provides a clinical safety net that enables care in the least restrictive setting for people with complex clinical, social, and behavioral conditions. The firm’s Ibis recognizes emerging health issues and care gaps in real time, provides self-care protocols, and alerts the care team to early intervention opportunities, avoiding the need for hospitalization using patent-pending artificial intelligence. The company was founded by Pilai De, Hugh Franklin Stoddart and Hugh A. Stoddart in 2010 and is headquartered in Boxborough, MA.

Senscio Systems, Inc. develops digital health solutions that provide information and support for consumers and clinicians. It offers Ibis solution, which provides a clinical safety net that enables care in the least restrictive setting for people with complex clinical, social, and behavioral conditions. The firm’s Ibis recognizes emerging health issues and care gaps in real time, provides self-care protocols, and alerts the care team to early intervention opportunities, avoiding the need for hospitalization using patent-pending artificial intelligence. The company was founded by Pilai De, Hugh Franklin Stoddart and Hugh A. Stoddart in 2010 and is headquartered in Boxborough, MA.

Senscio Systems, Inc. develops digital health solutions that provide information and support for consumers and clinicians. It offers Ibis solution, which provides a clinical safety net that enables care in the least restrictive setting for people with complex clinical, social, and behavioral conditions. The firm’s Ibis recognizes emerging health issues and care gaps in real time, provides self-care protocols, and alerts the care team to early intervention opportunities, avoiding the need for hospitalization using patent-pending artificial intelligence. The company was founded by Pilai De, Hugh Franklin Stoddart and Hugh A. Stoddart in 2010 and is headquartered in Boxborough, MA.

Thermalin, Inc. engages in the development of insulin products for patients with diabetes. It offers stabilized, ultra-rapid, and highly concentrated; no refrigeration basal and mix; glucose-responsive smart basal; and StampPump insulins. The company was founded by Michael A. Weiss, Bruce H. Frank, and Richard Berenson in 2010 and is headquartered in Cleveland, OH.

HemoShear Therapeutics LLC engages in the development of human-relevant systems for applications in drug research and development. It creates human relevant systems that replicate the biology of organ systems and diseases throughout drug discovery and development. The firm's technology imposes human-derived hemodynamic forces on human primary cells to recreate human biology. The company was founded by Brian R. Wamhoff and Brett R. Blackman in 2008 and is headquartered in Charlottesville, VA.

HemoShear Therapeutics LLC engages in the development of human-relevant systems for applications in drug research and development. It creates human relevant systems that replicate the biology of organ systems and diseases throughout drug discovery and development. The firm's technology imposes human-derived hemodynamic forces on human primary cells to recreate human biology. The company was founded by Brian R. Wamhoff and Brett R. Blackman in 2008 and is headquartered in Charlottesville, VA.

HemoShear Therapeutics LLC engages in the development of human-relevant systems for applications in drug research and development. It creates human relevant systems that replicate the biology of organ systems and diseases throughout drug discovery and development. The firm's technology imposes human-derived hemodynamic forces on human primary cells to recreate human biology. The company was founded by Brian R. Wamhoff and Brett R. Blackman in 2008 and is headquartered in Charlottesville, VA.

Noxilizer, Inc. engages in the provision of room temperature nitrogen dioxide sterilization technology. It sells sterilization equipment and biodecontamination equipment to pharmaceutical, biotech, and medical device manufacturers and also offers contract sterilization services. The company was founded in 2004 and is headquartered in Baltimore, MD.

Thermalin, Inc. engages in the development of insulin products for patients with diabetes. It offers stabilized, ultra-rapid, and highly concentrated; no refrigeration basal and mix; glucose-responsive smart basal; and StampPump insulins. The company was founded by Michael A. Weiss, Bruce H. Frank, and Richard Berenson in 2010 and is headquartered in Cleveland, OH.

HemoShear Therapeutics LLC engages in the development of human-relevant systems for applications in drug research and development. It creates human relevant systems that replicate the biology of organ systems and diseases throughout drug discovery and development. The firm's technology imposes human-derived hemodynamic forces on human primary cells to recreate human biology. The company was founded by Brian R. Wamhoff and Brett R. Blackman in 2008 and is headquartered in Charlottesville, VA.

Thermalin, Inc. engages in the development of insulin products for patients with diabetes. It offers stabilized, ultra-rapid, and highly concentrated; no refrigeration basal and mix; glucose-responsive smart basal; and StampPump insulins. The company was founded by Michael A. Weiss, Bruce H. Frank, and Richard Berenson in 2010 and is headquartered in Cleveland, OH.

Hygieia, Inc. engages in the provision of healthcare services focusing on insulin management. It offers the d-Nav Insulin Management Program. The company was founded by Israel Hodish and Eran Bashan in 2008 and is headquartered in Livonia, MI.

HemoShear Therapeutics LLC engages in the development of human-relevant systems for applications in drug research and development. It creates human relevant systems that replicate the biology of organ systems and diseases throughout drug discovery and development. The firm's technology imposes human-derived hemodynamic forces on human primary cells to recreate human biology. The company was founded by Brian R. Wamhoff and Brett R. Blackman in 2008 and is headquartered in Charlottesville, VA.

Theromics, Inc. is a medical device technology company that is developing a next-generation thermal accelerant technology for soft tissue ablation procedures and combination therapy. The company is based in West Bridgewater, MA. The company's proprietary heatsync™ gel is based on a protein naturally found in the body and may increase cost-efficiencies and improve outcomes through more focused and patient-centric delivery. The company will first focus on tumor ablations and then expand into additional applications, including pain and abnormal uterine bleeding. Longer-term, Theromics plans to apply its thermal technology for use as an oncolytic intratumoral drug/immunotherapy delivery platform with the potential to enhance efficacy and improve safety profiles of currently approved medicines. The company was founded by Damian E. Dupuy, William Keun Chan Park. The CEO is Ron Murphy.

Population Health Alliance is a professional and trade association that has been advocating for population health management for over 20 years. The private company is based in Washington. The American company believes that applying the principles of population health improvement will lead to better health outcomes for all individuals and populations.

Population Health Alliance is a professional and trade association that has been advocating for population health management for over 20 years. The private company is based in Washington. The American company believes that applying the principles of population health improvement will lead to better health outcomes for all individuals and populations.

Noxilizer, Inc. engages in the provision of room temperature nitrogen dioxide sterilization technology. It sells sterilization equipment and biodecontamination equipment to pharmaceutical, biotech, and medical device manufacturers and also offers contract sterilization services. The company was founded in 2004 and is headquartered in Baltimore, MD.

Massachusetts Medical Device Industry Council, also known as MassMEDIC, is the largest regional medtech association in Massachusetts. With over 300 members, the organization represents manufacturers, product developers, suppliers, research institutions, and academic health centers.

T1D Exchange is a nonprofit organization that was established in 2010 with initial and ongoing support from the Leona M. and Harry B. Helmsley Charitable Trust. T1D Exchange is based in Boston, MA. The non-profit company is dedicated to improving outcomes for the entire T1D population through real-world evidence and clinical data collection and analysis. T1D Exchange is a leading provider of real-world evidence, identifying gaps in data and redefining best practices to improve the lives of those living with T1D. The company actively supports quality improvement and innovation through its quality improvement collaborative, patient registry, and data-oriented research services. David Walton has been the CEO of the company since 2018.

Massachusetts Medical Device Industry Council, also known as MassMEDIC, is the largest regional medtech association in Massachusetts. With over 300 members, the organization represents manufacturers, product developers, suppliers, research institutions, and academic health centers.

Noxilizer, Inc. engages in the provision of room temperature nitrogen dioxide sterilization technology. It sells sterilization equipment and biodecontamination equipment to pharmaceutical, biotech, and medical device manufacturers and also offers contract sterilization services. The company was founded in 2004 and is headquartered in Baltimore, MD.

Massachusetts Medical Device Industry Council, also known as MassMEDIC, is the largest regional medtech association in Massachusetts. With over 300 members, the organization represents manufacturers, product developers, suppliers, research institutions, and academic health centers.

Massachusetts Medical Device Industry Council, also known as MassMEDIC, is the largest regional medtech association in Massachusetts. With over 300 members, the organization represents manufacturers, product developers, suppliers, research institutions, and academic health centers.

HemoShear Therapeutics LLC engages in the development of human-relevant systems for applications in drug research and development. It creates human relevant systems that replicate the biology of organ systems and diseases throughout drug discovery and development. The firm's technology imposes human-derived hemodynamic forces on human primary cells to recreate human biology. The company was founded by Brian R. Wamhoff and Brett R. Blackman in 2008 and is headquartered in Charlottesville, VA.

Noxilizer, Inc. engages in the provision of room temperature nitrogen dioxide sterilization technology. It sells sterilization equipment and biodecontamination equipment to pharmaceutical, biotech, and medical device manufacturers and also offers contract sterilization services. The company was founded in 2004 and is headquartered in Baltimore, MD.

Massachusetts Medical Device Industry Council, also known as MassMEDIC, is the largest regional medtech association in Massachusetts. With over 300 members, the organization represents manufacturers, product developers, suppliers, research institutions, and academic health centers.

HemoShear Therapeutics LLC engages in the development of human-relevant systems for applications in drug research and development. It creates human relevant systems that replicate the biology of organ systems and diseases throughout drug discovery and development. The firm's technology imposes human-derived hemodynamic forces on human primary cells to recreate human biology. The company was founded by Brian R. Wamhoff and Brett R. Blackman in 2008 and is headquartered in Charlottesville, VA.

Noxilizer, Inc. engages in the provision of room temperature nitrogen dioxide sterilization technology. It sells sterilization equipment and biodecontamination equipment to pharmaceutical, biotech, and medical device manufacturers and also offers contract sterilization services. The company was founded in 2004 and is headquartered in Baltimore, MD.

Noxilizer, Inc. engages in the provision of room temperature nitrogen dioxide sterilization technology. It sells sterilization equipment and biodecontamination equipment to pharmaceutical, biotech, and medical device manufacturers and also offers contract sterilization services. The company was founded in 2004 and is headquartered in Baltimore, MD.

Massachusetts Medical Device Industry Council, also known as MassMEDIC, is the largest regional medtech association in Massachusetts. With over 300 members, the organization represents manufacturers, product developers, suppliers, research institutions, and academic health centers.